FOOD AND DRUG ADMINISTRATION
1950
NOTICES OF JUDGMENT UNDER THE FEDERAL FOOD, DRUG,
AND COSMETIC ACT
[Given pursuant to section 705 of the Food, Drug, and Cosmetic Act]
2731-2750
DRUGS AND DEVICES
The cases reported herewith were instituted in the United States district
courts by the United States attorneys, acting upon reports submitted by the
Federal Security Agency. Published by direction of the Federal Security
Administrator.
PAUL B. DUNBAR, Commissioner of Food and Drugs.
WASHINGTON, D. C, January 3,1950.
Page
Drugs and devices actionable be-
cause of failure to bear ade-
quate directions or warning
statements
367
CONTENTS*
Page
Drugs actionable because of devia-   '
tion from official or*own stand-
ards. 
371
Drugs and devices actionable be-
cause of false and misleading
claims. 
373
Drugs for human use.__ __ 373
Drugs for veterinary use 
376
Drugs actionable because of omis-
sion of, or unsatisfactory, in-
gredients statements 
377
DRUGS AND DEVICES ACTIONABLE BECAUSE OF FAIL-
URE TO BEAR ADEQUATE DIRECTIONS OR WARNING
STATEMENTS
2731. Misbranding of Nanette Hormone Cream. U. S. v. Nix Cosmetics Co., Inc.
Plea of nolo contendere. Fine, $800. (F. D. C. No. 23603. Sample Nos.
50260-H, 61334-H to 61336-H, incl.)
INFORMATION FILED :   May 20, 1949, Western District of Tennessee, against the
Nix Cosmetics Co., Inc., Memphis, Tenn.
ALLEGED SHIPMENT:   Between the approximate dates of April 30, 1946, and
March 21,1947, from the State of Tennessee into the States of Alabama and
Pennsylvania.
LABEL, IN PAST:   "Nanette Hormone Cream   *   *    *   Distributed By-Nan-
ette Company   Memphis 1, Tenn."
?For failure to bear a label containing an accurate statement of the quantity of the contents, No. 2732;
failure to bear a label containing the name and place of business of the manufacturer, packer, or distribu*
tor, No. 2733; cosmetic, subject to the drug provisions of the Act, No. 2731.
854459-49 
367
and the label statement "Each 2 Oz. Contains 5 Mgs. Stilbestrol (Synthetic
Estrogenic Substance)" were false and misleading since the name and the
statement represented and suggested that the article contained a hormone and
that it would exert a beneficial hormone-like, or beneficial estrogenic, effect upon
the body when used as directed. The article did not contain a hormone and
would produce no beneficial hormone-like, or beneficial estrogenic, effect upon
the body when used as directed.
Further misbranding, Section 502 (f) (1), the directions for use in the label-
ing "Apply gently V2 heaping teaspoonful at bedtime. Leave on overnight"
were inadequate since they failed to indicate the conditions in which the
article was to be used, the body area to which the article was to be applied,
and the duration of its use.
DISPOSITION: May 20, 1949. A plea of nolo contendere having been entered,
the court imposed a fine of $800.